{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:53:46Z","timestamp":1792076026745,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.eclinm.2021.101218","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T12:43:03Z","timestamp":1638276183000},"page":"101218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["A phase 2\/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India"],"prefix":"10.1016","volume":"42","author":[{"given":"Prasad S","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrasekaran","family":"Padmapriyadarsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Vekemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Bavdekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B S","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya J","family":"Gogtay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muralidhar","family":"Tambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Lalwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiranjit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushant","family":"Meshram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T S","family":"Selvavinayagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devi Madhavi","family":"Bhimarasetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S R","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetanraj","family":"Bhamare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijeet","family":"Dharmadhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Vadakkedath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille J","family":"Bonhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuri","family":"Thakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarali N","family":"Kurle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2848-3089","authenticated-orcid":false,"given":"Manish","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiran","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balram","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Shaligram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhananjay","family":"Kapse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwat","family":"Gunale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2021.101218_bib0001","unstructured":"World Health Organization (WHO). WHO Director-General's opening remarks at the media briefing on COVID-19. March 11, 2020. https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-COVID-19-11-march-2020 (accessed Jul 5, 2021)."},{"key":"10.1016\/j.eclinm.2021.101218_bib0002","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2021.101218_bib0003","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2021.101218_bib0004","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2021.101218_bib0005","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(21)00432-3","article-title":"Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2021.101218_bib0006","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","article-title":"Efficacy of the ChAdOx1 nCoV-19 COVID-19 Vaccine against the B.1.351 Variant","volume":"384","author":"Madhi","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2021.101218_bib0007","unstructured":"AstraZeneca PLC. AstraZeneca's COVID-19 vaccine authorised for emergency supply in the UK. December 30, 2020. https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2020\/astrazenecas-COVID-19-vaccine-authorised-in-uk.html (accessed Jul 5, 2021)."},{"key":"10.1016\/j.eclinm.2021.101218_bib0008","unstructured":"AstraZeneca PLC. AstraZeneca takes next steps towards broad and equitable access to Oxford University's potential COVID-19 vaccine. June 4, 2020. https:\/\/www.astrazeneca.com\/media-centre\/articles\/2020\/astrazeneca-takes-next-steps-towards-broad-and-equitable-access-to-oxford-universitys-potential-COVID-19-vaccine.html (accessed Jul 5, 2021)."},{"key":"10.1016\/j.eclinm.2021.101218_bib0009","unstructured":"Ministry of Health and Family Welfare, India. Press statement by the Drugs Controller General of India (DCGI) on Restricted Emergency approval of COVID-19 virus vaccine. January 3, 2021. https:\/\/pib.gov.in\/PressReleasePage.aspx?PRID=1685761 (accessed Jul 5, 2021)."},{"key":"10.1016\/j.eclinm.2021.101218_bib0010","unstructured":"World Health Organization (WHO). WHO lists two additional COVID-19 vaccines for emergency use and COVAX roll-out. February 15, 2021. https:\/\/www.who.int\/news\/item\/15-02-2021-who-lists-two-additional-COVID-19-vaccines-for-emergency-use-and-covax-roll-out (accessed Jul 5, 2021)."},{"key":"10.1016\/j.eclinm.2021.101218_bib0011","unstructured":"Ministry of Health and Family Welfare, India. Co-Win \u2013 Winning Over COVID_19. https:\/\/dashboard.cowin.gov.in\/ (accessed Jul 5, 2021)."},{"key":"10.1016\/j.eclinm.2021.101218_bib0012","unstructured":"Our World in Data. Coronavirus (COVID-19) Vaccinations. https:\/\/ourworldindata.org\/covid-vaccinations (accessed Jul 5, 2021)."},{"key":"10.1016\/j.eclinm.2021.101218_bib0013","unstructured":"World Health Organization (WHO) Expert Committee on Biological Standardization. Establishment of the WHO International Standard and Reference Panel for anti-SARS-CoV-2 antibody. WHO\/BS\/2020.2403. December 9\u201310, 2020. https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/ecbs\/bs-2020-2403-sars-cov-2-ab-ik-17-nov-2020_4ef4fdae-e1ce-4ba7-b21a-d725c68b152b.pdf?sfvrsn=662b46ae8&download=true (accessed Jul 28, 2021)."},{"key":"10.1016\/j.eclinm.2021.101218_bib0014","unstructured":"World Health Organization (WHO). Guidelines on clinical evaluation of vaccines: regulatory expectations. WHO Technical Report Series 1004, Annex 9, 2017. October 21, 2020. https:\/\/www.who.int\/publications\/m\/item\/WHO-TRS-1004-web-annex-9 (accessed Jul 27, 2021)."},{"key":"10.1016\/j.eclinm.2021.101218_bib0015","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","article-title":"A minimal common outcome measure set for COVID-19 clinical research","volume":"20","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eclinm.2021.101218_bib0016","unstructured":"UK Medicines and Healthcare products Regulatory Agency. Summary of Product Characteristics for COVID-19 Vaccine AstraZeneca. Updated June 25, 2021. https:\/\/www.gov.uk\/government\/publications\/regulatory-approval-of-COVID-19-vaccine-astrazeneca\/information-for-healthcare-professionals-on-COVID-19-vaccine-astrazeneca (accessed Jul 6, 2021)."},{"key":"10.1016\/j.eclinm.2021.101218_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)01693-7","article-title":"Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis","author":"Bhuyan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2021.101218_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101038","article-title":"A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers- first results from India","volume":"38","author":"Kaur","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.eclinm.2021.101218_bib0019","unstructured":"World Health Organization (WHO). Information Sheet: Observed rate of vaccine reactions \u2013 Diphtheria, Pertussis, Tetanus vaccines. May 2014. https:\/\/www.who.int\/vaccine_safety\/initiative\/tools\/DTP_vaccine_rates_information_sheet.pdf (accessed Jul 8, 2021)."},{"key":"10.1016\/j.eclinm.2021.101218_bib0020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41591-020-01179-4","article-title":"Phase 1\/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses","volume":"27","author":"Barrett","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.eclinm.2021.101218_bib0021","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","article-title":"T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.eclinm.2021.101218_bib0022","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/s41467-021-22958-8","article-title":"Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival","volume":"12","author":"Dispinseri","year":"2021","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.eclinm.2021.101218_bib0023","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.mayocp.2021.06.003","article-title":"Protective Effect of COVID-19 Vaccine Among Health Care Workers During the Second Wave of the Pandemic in India","volume":"96","author":"Victor","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.eclinm.2021.101218_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2021.08.005","article-title":"ChAdOx1 nCoV-19 effectiveness during an unprecedented surge in SARS COV-2 infections","author":"Satwik","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.eclinm.2021.101218_bib0025","article-title":"Occurrence of COVID-19 in priority groups receiving ChAdOx1 nCoV-19 coronavirus vaccine (recombinant): a preliminary analysis from north India","author":"Kaur","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.eclinm.2021.101218_bib0026","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41541-021-00292-w","article-title":"SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates","volume":"6","author":"Kyriakidis","year":"2021","journal-title":"NPJ Vaccines"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021004995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021004995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:10:00Z","timestamp":1762888200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537021004995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":26,"alternative-id":["S2589537021004995"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101218","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase 2\/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101218"}}